- Home
- CATO vs MREO Comparison
CATO vs MREO Comparison
Compare CATO & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATO | MREO |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0M | 52.5M |
| IPO Year | 1994 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CATO | MREO |
|---|---|---|
| Price | $2.87 | $0.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 42.2K | ★ 1.7M |
| Earning Date | 05-21-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 68.04 | 16.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $653,812,000.00 | $500,000.00 |
| Revenue This Year | N/A | $5,184.20 |
| Revenue Next Year | N/A | $55.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.62 | N/A |
| 52 Week Low | $2.41 | $0.20 |
| 52 Week High | $4.92 | $2.94 |
Technical Indicators
Market Signals| Indicator | CATO | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 30.70 |
| Support Level | $2.90 | $0.20 |
| Resistance Level | $3.20 | $0.36 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 36.12 | 21.45 |
Price Performance
Historical ComparisonAbout CATO Cato Corporation (The)
The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).